단백질 결정화 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별(장비, 소모품, 소프트웨어 및 서비스), 기술별, 최종사용자별, 지역별, 경쟁사별(2019-2029년)

Global Protein Crystallization Market was valued at USD 1.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 8.25% through 2029.

Protein crystallization is a crucial step in the process of determining the structure of proteins, which is vital for drug discovery, biomedical research, and understanding various biological processes. The global protein crystallization market plays a significant role in facilitating advancements in pharmaceuticals, biotechnology, and structural biology. Recent advancements in protein crystallization techniques, such as high-throughput screening methods, automated systems, and novel crystallization reagents, have significantly enhanced the efficiency and success rate of protein crystallization experiments. These technological innovations are driving the growth of the protein crystallization market by offering researchers better tools to accelerate their research and drug development processes.

Structural biology plays a crucial role in understanding the molecular mechanisms of diseases and designing targeted therapies. As the demand for structural information on proteins continues to rise, there is a corresponding increase in the demand for protein crystallization services and products. This trend is fueled by the growing focus on precision medicine and personalized therapeutics, where detailed structural insights are essential for drug design and optimization. The biopharmaceutical industry is experiencing robust growth, driven by the increasing prevalence of chronic diseases, advancements in biotechnology, and the demand for innovative therapies. Protein crystallization is integral to the drug discovery and development process in the biopharmaceutical industry, driving the demand for protein crystallization services and products. As a result, the expansion of the biopharmaceutical sector is propelling the growth of the global protein crystallization market.

Key Market Drivers

Increasing Demand for Drug Discovery and Development is Driving the Global Protein Crystallization Market

In the realm of pharmaceuticals, the quest for innovative drugs to combat various diseases is an ongoing battle. A crucial aspect of this endeavor is protein crystallization, a process fundamental to drug discovery and development. The global protein crystallization market is witnessing substantial growth, primarily fueled by the escalating demand for novel therapeutics. The increasing prevalence of complex diseases coupled with the rise of personalized medicine has spurred pharmaceutical companies and research institutions to intensify their efforts in drug discovery. Targeted therapies, precision medicine, and biologics are becoming increasingly prevalent in the pharmaceutical landscape, necessitating the exploration of diverse proteins for therapeutic intervention. Protein crystallization serves as a cornerstone in drug discovery by facilitating the determination of protein structures. This structural insight is indispensable for understanding the mechanisms of disease and designing drugs that specifically target the implicated proteins. Moreover, protein crystallization enables the screening of potential drug candidates through techniques like X-ray crystallography and cryo-electron microscopy, aiding in the identification of promising compounds for further development.

Recent advancements in protein crystallization techniques and instrumentation have significantly enhanced the efficiency and success rates of drug discovery endeavors. Automation and high-throughput screening capabilities have streamlined the protein crystallization process, enabling researchers to screen a vast array of conditions rapidly. Additionally, innovations in protein engineering and formulation have expanded the repertoire of proteins amenable to crystallization, further driving market growth. Collaborative efforts between academia, industry, and government agencies have catalyzed research in protein crystallization and drug discovery. Public-private partnerships, consortia, and funding initiatives aimed at advancing drug development have provided the necessary resources and infrastructure to accelerate innovation in the field. Such collaborative endeavors foster knowledge exchange, resource sharing, and cross-disciplinary collaborations, fostering a conducive environment for market growth.

Increasing Research Funding and Investments is Driving the Global Protein Crystallization Market

Protein crystallization, a fundamental aspect of structural biology, has emerged as a crucial technique for understanding the structure and function of proteins. With proteins being the building blocks of life and playing pivotal roles in various biological processes, the ability to determine their structures accurately is essential for advancing fields such as drug discovery, biotechnology, and molecular biology. In recent years, the global protein crystallization market has witnessed significant growth, largely attributed to the increasing research funding and investments pouring into the field. Several factors are driving the growth of the global protein crystallization market, with increasing research funding and investments being a primary catalyst. Governments, academic institutions, and private organizations are allocating substantial resources to support research in structural biology, protein science, and drug discovery. This funding not only fuels basic research but also enables the development of innovative technologies and tools for protein crystallization and structural analysis. Moreover, advancements in protein engineering, computational modeling, and automation have revolutionized the protein crystallization process, making it more efficient and accessible to researchers. High-throughput screening platforms, robotic systems, and novel crystallization techniques have streamlined the process of crystallizing proteins, reducing time and resource requirements. As a result, researchers can screen a larger number of protein targets and optimize crystallization conditions more effectively, leading to an increase in successful structure determinations. Additionally, the growing demand for biopharmaceuticals and personalized medicine has spurred investments in protein crystallization technologies. Biopharmaceutical companies are leveraging structural biology techniques to accelerate drug discovery and development pipelines, leading to a greater demand for protein crystallization services and instrumentation. Furthermore, the expansion of the biotechnology and pharmaceutical industries in emerging markets, coupled with advancements in protein expression and purification technologies, is driving the adoption of protein crystallization techniques globally.

Key Market Challenges

Limited Success Rates

Proteins are complex molecules with diverse structures, making their crystallization a challenging task. The process is influenced by various factors such as protein purity, concentration, pH, temperature, and the presence of additives. Achieving optimal conditions for crystallization requires meticulous experimentation and optimization. The quality and purity of protein samples significantly impact crystallization success rates. Impurities, degradation, or conformational heterogeneity can hinder the formation of well-ordered crystals. Obtaining high-quality protein samples often involves laborious purification procedures, which may not always guarantee success. Protein crystallization typically requires large quantities of purified protein, which can be a limiting factor, especially for proteins that are difficult to express or purify. Producing sufficient quantities of protein for crystallization experiments can be time-consuming and resource-intensive. Proteins exhibit diverse structural properties, ranging from small globular proteins to large multi-domain complexes. Crystallizing proteins with specific structural features, such as membrane proteins or intrinsically disordered proteins, presents additional challenges due to their unique characteristics and interactions.

Achieving reproducible results across different experimental conditions and laboratories is crucial for advancing protein crystallization research. However, variability in experimental protocols, equipment, and environmental factors can affect the reproducibility and robustness of crystallization outcomes.

Key Market Trends

Technological Advancements

In recent years, technological advancements have been propelling various industries forward, and the protein crystallization market is no exception. Protein crystallization, a crucial step in structural biology and drug discovery, has seen significant growth due to advancements in techniques, instrumentation, and automation. Automation and robotics have revolutionized protein crystallization by streamlining processes and increasing throughput. Automated liquid handling systems, robotic arms, and imaging systems have significantly improved the efficiency and reproducibility of protein crystallization experiments. These advancements enable high-throughput screening of crystallization conditions, leading to faster discovery of protein structures.

HTS platforms have become increasingly sophisticated, allowing researchers to screen thousands of crystallization conditions simultaneously. These platforms utilize advanced imaging techniques and data analysis algorithms to identify promising crystallization conditions quickly. By accelerating the screening process, HTS platforms save time and resources, driving the adoption of protein crystallization in both academic and industrial settings. Microfluidic devices and lab-on-a-chip technologies offer precise control over fluid handling and manipulation, making them ideal for protein crystallization experiments. These miniature systems enable researchers to perform experiments with minimal sample consumption and high reproducibility. Microfluidic-based protein crystallization platforms also facilitate the study of protein dynamics and kinetics, providing valuable insights into the crystallization process.

Cryo-EM has emerged as a powerful technique for determining protein structures at near-atomic resolution. Recent advancements in cryo-EM instrumentation and image processing algorithms have significantly improved its resolution and throughput. Cryo-EM complements traditional X-ray crystallography by providing structural information for proteins that are challenging to crystallize. As cryo-EM technology becomes more accessible and affordable, it is driving growth in the protein crystallization market.

Segmental Insights

Product Insights

Based on the category of Product, Consumables emerged as the dominant player in the global market for Protein Crystallization in 2023. Consumables encompass a wide range of products crucial for protein crystallization experiments, including crystallization plates, reagents, buffers, and screening kits. These consumables are essential for preparing protein samples, setting up crystallization experiments, and analyzing the resulting crystals. The growing demand for protein-based drugs and the need for understanding complex biological structures have led to a surge in research and development activities in the pharmaceutical and biotechnology sectors. As a result, there is a continuous demand for consumables in protein crystallization experiments. Advances in protein crystallization techniques and instrumentation have created a demand for specialized consumables that can meet the evolving needs of researchers. Manufacturers are investing in developing innovative consumables with improved performance, reproducibility, and ease of use, driving market growth.

Regional Insights

North America emerged as the dominant region in the global Protein Crystallization market in 2023, holding the largest market share in terms of value. North America boasts a robust ecosystem for research and development, particularly in the field of life sciences. Major pharmaceutical and biotechnology companies, along with prominent academic institutions, are continuously investing in protein crystallization research. These investments fuel the development of innovative technologies and methodologies, driving the growth of the protein crystallization market in the region.

Key Market Players

Rigaku Corporation

Mettler-Toledo International Inc.

Corning Incorporated

Greiner Bio-One International GmbH

HAMPTON RESEARCH CORP

Jena Bioscience GmbH

Bruker Corporation

Creative Proteomics

Molecular Dimensions Limited

Report Scope:

In this report, the Global Protein Crystallization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Crystallization Market, By Product:

Instruments Consumables Software & Services

Protein Crystallization Market, By Technology:

X-ray Crystallography Cryo-electron Microscopy NMR Spectroscopy Others

Protein Crystallization Market, By End User:

Pharmaceutical And Biotechnology Companies Academic And Research Institutes

Protein Crystallization Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Protein Crystallization Market.

Available Customizations:

Global Protein Crystallization market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Source
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Crystallization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments( Liquid Handling Instruments, Crystal Imaging Instruments), Consumables( Reagents & Kits/Screens, Micro Plates, Others), Software & Services)
  • 5.2.2. By Technology (X-ray Crystallography, Cryo-electron Microscopy, NMR Spectroscopy, Others)
  • 5.2.3. By End User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2023)
• 5.3. Market Map
  • 5.3.1. By Product
  • 5.3.2. By Technology
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Protein Crystallization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By End User
  • 6.2.4. By Country
    • 6.2.4.1. United States Protein Crystallization Market Outlook
      • 6.2.4.1.1. Market Size & Forecast
      • 6.2.4.1.1.1. By Value
      • 6.2.4.1.2. Market Share & Forecast
      • 6.2.4.1.2.1. By Product
      • 6.2.4.1.2.2. By Technology
      • 6.2.4.1.2.3. By End User
    • 6.2.4.2. Canada Protein Crystallization Market Outlook
      • 6.2.4.2.1. Market Size & Forecast
      • 6.2.4.2.1.1. By Value
      • 6.2.4.2.2. Market Share & Forecast
      • 6.2.4.2.2.1. By Product
      • 6.2.4.2.2.2. By Technology
      • 6.2.4.2.2.3. By End User
    • 6.2.4.3. Mexico Protein Crystallization Market Outlook
      • 6.2.4.3.1. Market Size & Forecast
      • 6.2.4.3.1.1. By Value
      • 6.2.4.3.2. Market Share & Forecast
      • 6.2.4.3.2.1. By Product
      • 6.2.4.3.2.2. By Technology
      • 6.2.4.3.2.3. By End User

7. Europe Protein Crystallization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By End User
  • 7.2.4. By Country
    • 7.2.4.1. France Protein Crystallization Market Outlook
      • 7.2.4.1.1. Market Size & Forecast
      • 7.2.4.1.1.1. By Value
      • 7.2.4.1.2. Market Share & Forecast
      • 7.2.4.1.2.1. By Product
      • 7.2.4.1.2.2. By Technology
      • 7.2.4.1.2.3. By End User
    • 7.2.4.2. Germany Protein Crystallization Market Outlook
      • 7.2.4.2.1. Market Size & Forecast
      • 7.2.4.2.1.1. By Value
      • 7.2.4.2.2. Market Share & Forecast
      • 7.2.4.2.2.1. By Product
      • 7.2.4.2.2.2. By Technology
      • 7.2.4.2.2.3. By End User
    • 7.2.4.3. United Kingdom Protein Crystallization Market Outlook
      • 7.2.4.3.1. Market Size & Forecast
      • 7.2.4.3.1.1. By Value
      • 7.2.4.3.2. Market Share & Forecast
      • 7.2.4.3.2.1. By Product
      • 7.2.4.3.2.2. By Technology
      • 7.2.4.3.2.3. By End User
    • 7.2.4.4. Italy Protein Crystallization Market Outlook
      • 7.2.4.4.1. Market Size & Forecast
      • 7.2.4.4.1.1. By Value
      • 7.2.4.4.2. Market Share & Forecast
      • 7.2.4.4.2.1. By Product
      • 7.2.4.4.2.2. By Technology
      • 7.2.4.4.2.3. By End User
    • 7.2.4.5. Spain Protein Crystallization Market Outlook
      • 7.2.4.5.1. Market Size & Forecast
      • 7.2.4.5.1.1. By Value
      • 7.2.4.5.2. Market Share & Forecast
      • 7.2.4.5.2.1. By Product
      • 7.2.4.5.2.2. By Technology
      • 7.2.4.5.2.3. By End User

8. Asia Pacific Protein Crystallization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By End User
  • 8.2.4. By Country
    • 8.2.4.1. China Protein Crystallization Market Outlook
      • 8.2.4.1.1. Market Size & Forecast
      • 8.2.4.1.1.1. By Value
      • 8.2.4.1.2. Market Share & Forecast
      • 8.2.4.1.2.1. By Product
      • 8.2.4.1.2.2. By Technology
      • 8.2.4.1.2.3. By End User
    • 8.2.4.2. India Protein Crystallization Market Outlook
      • 8.2.4.2.1. Market Size & Forecast
      • 8.2.4.2.1.1. By Value
      • 8.2.4.2.2. Market Share & Forecast
      • 8.2.4.2.2.1. By Product
      • 8.2.4.2.2.2. By Technology
      • 8.2.4.2.2.3. By End User
    • 8.2.4.3. South Korea Protein Crystallization Market Outlook
      • 8.2.4.3.1. Market Size & Forecast
      • 8.2.4.3.1.1. By Value
      • 8.2.4.3.2. Market Share & Forecast
      • 8.2.4.3.2.1. By Product
      • 8.2.4.3.2.2. By Technology
      • 8.2.4.3.2.3. By End User
    • 8.2.4.4. Japan Protein Crystallization Market Outlook
      • 8.2.4.4.1. Market Size & Forecast
      • 8.2.4.4.1.1. By Value
      • 8.2.4.4.2. Market Share & Forecast
      • 8.2.4.4.2.1. By Product
      • 8.2.4.4.2.2. By Technology
      • 8.2.4.4.2.3. By End User
    • 8.2.4.5. Australia Protein Crystallization Market Outlook
      • 8.2.4.5.1. Market Size & Forecast
      • 8.2.4.5.1.1. By Value
      • 8.2.4.5.2. Market Share & Forecast
      • 8.2.4.5.2.1. By Product
      • 8.2.4.5.2.2. By Technology
      • 8.2.4.5.2.3. By End User

9. South America Protein Crystallization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By End User
  • 9.2.4. By Country
    • 9.2.4.1. Brazil Protein Crystallization Market Outlook
      • 9.2.4.1.1. Market Size & Forecast
      • 9.2.4.1.1.1. By Value
      • 9.2.4.1.2. Market Share & Forecast
      • 9.2.4.1.2.1. By Product
      • 9.2.4.1.2.2. By Technology
      • 9.2.4.1.2.3. By End User
    • 9.2.4.2. Argentina Protein Crystallization Market Outlook
      • 9.2.4.2.1. Market Size & Forecast
      • 9.2.4.2.1.1. By Value
      • 9.2.4.2.2. Market Share & Forecast
      • 9.2.4.2.2.1. By Product
      • 9.2.4.2.2.2. By Technology
      • 9.2.4.2.2.3. By End User
    • 9.2.4.3. Colombia Protein Crystallization Market Outlook
      • 9.2.4.3.1. Market Size & Forecast
      • 9.2.4.3.1.1. By Value
      • 9.2.4.3.2. Market Share & Forecast
      • 9.2.4.3.2.1. By Product
      • 9.2.4.3.2.2. By Technology
      • 9.2.4.3.2.3. By End User

10. Middle East & Africa Protein Crystallization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By End User
  • 10.2.4. By Country
    • 10.2.4.1. South Africa Protein Crystallization Market Outlook
      • 10.2.4.1.1. Market Size & Forecast
      • 10.2.4.1.1.1. By Value
      • 10.2.4.1.2. Market Share & Forecast
      • 10.2.4.1.2.1. By Product
      • 10.2.4.1.2.2. By Technology
      • 10.2.4.1.2.3. By End User
    • 10.2.4.2. Saudi Arabia Protein Crystallization Market Outlook
      • 10.2.4.2.1. Market Size & Forecast
      • 10.2.4.2.1.1. By Value
      • 10.2.4.2.2. Market Share & Forecast
      • 10.2.4.2.2.1. By Product
      • 10.2.4.2.2.2. By Technology
      • 10.2.4.2.2.3. By End User
    • 10.2.4.3. UAE Protein Crystallization Market Outlook
      • 10.2.4.3.1. Market Size & Forecast
      • 10.2.4.3.1.1. By Value
      • 10.2.4.3.2. Market Share & Forecast
      • 10.2.4.3.2.1. By Product
      • 10.2.4.3.2.2. By Technology
      • 10.2.4.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Rigaku Corporation
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As Reported)
  • 13.1.5. Recent Developments
  • 13.1.6. Key Personnel Details
  • 13.1.7. SWOT Analysis
• 13.2. Mettler-Toledo International Inc.
• 13.3. Corning Incorporated
• 13.4. Greiner Bio-One International GmbH
• 13.5. HAMPTON RESEARCH CORP
• 13.6. Jena Bioscience GmbH
• 13.7. Bruker Corporation
• 13.8. Creative Proteomics
• 13.9. Molecular Dimensions Limited

14. Strategic Recommendations

15. About us & Disclaimer